Rakuten Medical, Inc., a global biotechnology company developing and commercializing its proprietary Alluminox® platform-based photoimmunotherapy, today announced the closing of a $100 million Series...
Prudentia Sciences, a pioneer in AI-native due diligence for life sciences dealmaking, today announced that it has secured $20 million in Series A financing....
STRM.BIO, a biotechnology company pioneering non-viral delivery technologies for in vivo cell and gene therapy, today announced $8 million in Series Seed 2 financing. The financing...
Array Labs today announced a $20M Series A financing led by Catapult Ventures, with participation from Washington Harbour Partners, Kompas VC, and other new...
BriefCatch, the essential legal writing AI platform, secures $6 million in Series A financing led by Full In to accelerate advanced platform development and...
EpilepsyGTx, a biotechnology company focused on research and development of cutting-edge gene therapies to treat refractory epilepsy, today announced it has raised $33 million...
“This fundraise is a pivotal milestone in our mission to industrialise cell therapy manufacturing,” said Edwin Stone, CEO, Cellular Origins. “The support from our investors is...
Neural Concept, a global AI platform and leader in Engineering Intelligence powering next-generation product development, today announced it raised a $100 million Series C...
we announced our $34 million Series A funding round led by Andreessen Horowitz, with participation from Bessemer Venture Partners, Long Journey Ventures, BoxGroup, and Trust...
